Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$22.30 USD
-0.20 (-0.89%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $22.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-1.11 | 1.48% |
Earnings Summary
For their last quarter, Viridian Therapeutics (VRDN) reported earnings of -$1.02 per share, missing the Zacks Consensus Estimate of -$0.87 per share. This reflects a negative earnings surprise of 17.24%. Look out for VRDN's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$1.11 per share, reflecting a year-over-year decrease of 1.83%.
Earnings History
Price & Consensus
Zacks News for VRDN
Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Lags Revenue Estimates
VRDN: What are Zacks experts saying now?
Zacks Private Portfolio Services